IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens

E. Bonifacio, V. Lampasona, P. J. Bingley

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

IA-2 (islet cell Ag 512) and IA-2β (phogrin/IAR) are related autoantigens associated with type 1 diabetes. To determine the critical regions for autoantibody binding and which of these autoantigens is the primary target, mutant and chimeric constructs were used to characterize Ab epitope binding in sera from 217 new onset patients with type 1 diabetes and sequential samples from 141 islet cell Ab positive first degree relatives of patients. All 22 relatives and 121 of 129 patients with IA-2/IA-2β Abs had reactivity to IA-2-specific epitopes. These epitopes were in the juxtamembrane region (residues 601-682) and the protein tyrosine phosphatase (PTP)-like domain of IA-2. Chimeras showed that IA-2 residues 795-889 were important for IA-2-specific Ab binding in the PTP-like domain, and mutation of IA-2 residues 877 and 911, previously indicated as relevant for phosphatase activity, also reduced Ab binding. In contrast, Ab binding to IA- 2β was limited to its PTP-like domain, most IA-2β Abs recognized epitopes shared with IA-2, and only 20 patients and 2 relatives had Abs to IA-2β- specific epitopes. In 4 relatives, IA-2 and/or IA-2β Abs developed in follow-up samples. In each of these, Abs to IA-2-specific epitopes were the first detected. In three, spreading to epitopes shared between IA-2 and IA- 2β in subsequent samples was seen. In the 17 relatives who developed type 1 diabetes, progression to disease was associated with reactivity to multiple IA-2/IA-2β epitopes. These data suggest that IA-2 is the primary phosphatase-like autoantigen associated with type 1 diabetes and that studying autoantibody epitope diversity may assist in disease prediction.

Original languageEnglish
Pages (from-to)2648-2654
Number of pages7
JournalJournal of Immunology
Volume161
Issue number5
Publication statusPublished - Sep 1 1998

Fingerprint

Class 8 Receptor-Like Protein Tyrosine Phosphatases
Autoantigens
Autoimmunity
Type 1 Diabetes Mellitus
Phosphoric Monoester Hydrolases
Tyrosine
Epitopes
Protein Tyrosine Phosphatases
Islets of Langerhans
Autoantibodies
Disease Progression
Carrier Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens. / Bonifacio, E.; Lampasona, V.; Bingley, P. J.

In: Journal of Immunology, Vol. 161, No. 5, 01.09.1998, p. 2648-2654.

Research output: Contribution to journalArticle

@article{78dbe82fc714414aac46ba00622e51db,
title = "IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens",
abstract = "IA-2 (islet cell Ag 512) and IA-2β (phogrin/IAR) are related autoantigens associated with type 1 diabetes. To determine the critical regions for autoantibody binding and which of these autoantigens is the primary target, mutant and chimeric constructs were used to characterize Ab epitope binding in sera from 217 new onset patients with type 1 diabetes and sequential samples from 141 islet cell Ab positive first degree relatives of patients. All 22 relatives and 121 of 129 patients with IA-2/IA-2β Abs had reactivity to IA-2-specific epitopes. These epitopes were in the juxtamembrane region (residues 601-682) and the protein tyrosine phosphatase (PTP)-like domain of IA-2. Chimeras showed that IA-2 residues 795-889 were important for IA-2-specific Ab binding in the PTP-like domain, and mutation of IA-2 residues 877 and 911, previously indicated as relevant for phosphatase activity, also reduced Ab binding. In contrast, Ab binding to IA- 2β was limited to its PTP-like domain, most IA-2β Abs recognized epitopes shared with IA-2, and only 20 patients and 2 relatives had Abs to IA-2β- specific epitopes. In 4 relatives, IA-2 and/or IA-2β Abs developed in follow-up samples. In each of these, Abs to IA-2-specific epitopes were the first detected. In three, spreading to epitopes shared between IA-2 and IA- 2β in subsequent samples was seen. In the 17 relatives who developed type 1 diabetes, progression to disease was associated with reactivity to multiple IA-2/IA-2β epitopes. These data suggest that IA-2 is the primary phosphatase-like autoantigen associated with type 1 diabetes and that studying autoantibody epitope diversity may assist in disease prediction.",
author = "E. Bonifacio and V. Lampasona and Bingley, {P. J.}",
year = "1998",
month = "9",
day = "1",
language = "English",
volume = "161",
pages = "2648--2654",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens

AU - Bonifacio, E.

AU - Lampasona, V.

AU - Bingley, P. J.

PY - 1998/9/1

Y1 - 1998/9/1

N2 - IA-2 (islet cell Ag 512) and IA-2β (phogrin/IAR) are related autoantigens associated with type 1 diabetes. To determine the critical regions for autoantibody binding and which of these autoantigens is the primary target, mutant and chimeric constructs were used to characterize Ab epitope binding in sera from 217 new onset patients with type 1 diabetes and sequential samples from 141 islet cell Ab positive first degree relatives of patients. All 22 relatives and 121 of 129 patients with IA-2/IA-2β Abs had reactivity to IA-2-specific epitopes. These epitopes were in the juxtamembrane region (residues 601-682) and the protein tyrosine phosphatase (PTP)-like domain of IA-2. Chimeras showed that IA-2 residues 795-889 were important for IA-2-specific Ab binding in the PTP-like domain, and mutation of IA-2 residues 877 and 911, previously indicated as relevant for phosphatase activity, also reduced Ab binding. In contrast, Ab binding to IA- 2β was limited to its PTP-like domain, most IA-2β Abs recognized epitopes shared with IA-2, and only 20 patients and 2 relatives had Abs to IA-2β- specific epitopes. In 4 relatives, IA-2 and/or IA-2β Abs developed in follow-up samples. In each of these, Abs to IA-2-specific epitopes were the first detected. In three, spreading to epitopes shared between IA-2 and IA- 2β in subsequent samples was seen. In the 17 relatives who developed type 1 diabetes, progression to disease was associated with reactivity to multiple IA-2/IA-2β epitopes. These data suggest that IA-2 is the primary phosphatase-like autoantigen associated with type 1 diabetes and that studying autoantibody epitope diversity may assist in disease prediction.

AB - IA-2 (islet cell Ag 512) and IA-2β (phogrin/IAR) are related autoantigens associated with type 1 diabetes. To determine the critical regions for autoantibody binding and which of these autoantigens is the primary target, mutant and chimeric constructs were used to characterize Ab epitope binding in sera from 217 new onset patients with type 1 diabetes and sequential samples from 141 islet cell Ab positive first degree relatives of patients. All 22 relatives and 121 of 129 patients with IA-2/IA-2β Abs had reactivity to IA-2-specific epitopes. These epitopes were in the juxtamembrane region (residues 601-682) and the protein tyrosine phosphatase (PTP)-like domain of IA-2. Chimeras showed that IA-2 residues 795-889 were important for IA-2-specific Ab binding in the PTP-like domain, and mutation of IA-2 residues 877 and 911, previously indicated as relevant for phosphatase activity, also reduced Ab binding. In contrast, Ab binding to IA- 2β was limited to its PTP-like domain, most IA-2β Abs recognized epitopes shared with IA-2, and only 20 patients and 2 relatives had Abs to IA-2β- specific epitopes. In 4 relatives, IA-2 and/or IA-2β Abs developed in follow-up samples. In each of these, Abs to IA-2-specific epitopes were the first detected. In three, spreading to epitopes shared between IA-2 and IA- 2β in subsequent samples was seen. In the 17 relatives who developed type 1 diabetes, progression to disease was associated with reactivity to multiple IA-2/IA-2β epitopes. These data suggest that IA-2 is the primary phosphatase-like autoantigen associated with type 1 diabetes and that studying autoantibody epitope diversity may assist in disease prediction.

UR - http://www.scopus.com/inward/record.url?scp=0032167450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032167450&partnerID=8YFLogxK

M3 - Article

C2 - 9725268

AN - SCOPUS:0032167450

VL - 161

SP - 2648

EP - 2654

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -